{"id":64588,"date":"2026-04-16T08:23:14","date_gmt":"2026-04-15T22:23:14","guid":{"rendered":"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=64588"},"modified":"2026-04-16T08:23:14","modified_gmt":"2026-04-15T22:23:14","slug":"84-4-of-cancer-patients-taking-ivermectin-mebendazole-reported-no-evidence-of-disease-tumor-regression-or-cancer-stabilization-after-6-months","status":"publish","type":"post","link":"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=64588","title":{"rendered":"84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-64589\" src=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/04\/Ivermection_Mebendazole_Cancer_Results.jpg\" alt=\"Ivermection Mebendazole Cancer Results\" width=\"1100\" height=\"902\" srcset=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/04\/Ivermection_Mebendazole_Cancer_Results.jpg 1100w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/04\/Ivermection_Mebendazole_Cancer_Results-300x246.jpg 300w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/04\/Ivermection_Mebendazole_Cancer_Results-1024x840.jpg 1024w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/04\/Ivermection_Mebendazole_Cancer_Results-768x630.jpg 768w\" sizes=\"auto, (max-width: 767px) 89vw, (max-width: 1000px) 54vw, (max-width: 1071px) 543px, 580px\" \/><\/p>\n<p>84.4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression, or cancer stabilization after 6 months.<\/p>\n<p>That kind of signal doesn\u2019t happen randomly. The key question is not just <em>what<\/em> we observed, but why.<\/p>\n<p>There are now <strong><a href=\"https:\/\/substack.com\/redirect\/60100a44-9e4a-4aeb-ae5a-cbe8e5539cc6?j=eyJ1IjoieWg4YXcifQ.P5dd96yeNjsZvqxez43LWKLeQBPn8oqoUB630mF8gtY\" rel=\"\">hundreds of preclinical studies<\/a><\/strong>\u2014in both cell systems and animal models\u2014showing that antiparasitic agents like ivermectin and mebendazole exert <strong>broad, multi-target anti-cancer effects across more than a dozen tumor types<\/strong>.<\/p>\n<p><a href=\"https:\/\/open.substack.com\/pub\/petermcculloughmd\/p\/844-of-cancer-patients-taking-ivermectin\">https:\/\/open.substack.com\/pub\/petermcculloughmd\/p\/844-of-cancer-patients-taking-ivermectin<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>84.4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression, or cancer stabilization after 6 months. That kind of signal doesn\u2019t happen randomly. The key question is not just what we observed, but why. There are now hundreds of preclinical studies\u2014in both cell systems and animal models\u2014showing that antiparasitic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=64588\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,6],"tags":[],"class_list":["post-64588","post","type-post","status-publish","format-standard","hentry","category-general-interest","category-health-tips"],"_links":{"self":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/64588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64588"}],"version-history":[{"count":1,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/64588\/revisions"}],"predecessor-version":[{"id":64590,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/64588\/revisions\/64590"}],"wp:attachment":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}